This is the authors' abstract. We don't add key points for this paper.
Short communication in response to the review of Turner et al. entitled "Ovarian cancer and the immune system - the role of targeted therapies" published in Gynecological Oncology. We believe systemic immune parameters might be a good alternative to tumor biopsy to gain insight in the immunological background of ovarian cancer.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Baert et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: